Point72 (Difc) LTD Uro Gen Pharma Ltd. Call Options Transaction History
Point72 (Difc) LTD
- $2.44 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$18.5 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$16.3 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$13.6 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$9.76 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$9.3 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $96.4M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...